Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Jinkerson, US

David L. Jinkerson, Benbrook, TX US

Patent application numberDescriptionPublished
20080208334COATED MEDICAL IMPLANTS AND LENSES - Coated medical implants have an implant body configured for securing in or adjacent to body tissue of a patient. The implant body has an implant surface and a coating is formed on at least a portion of the implant surface. The coating includes a coating outer surface of a first chemical component that is chemically bonded to a carboxylate functionality of a second chemical component. The second chemical component is immobilized by amide linkage to an underlying third chemical component that is plasma coated directly onto implant body surfaces. The coating either inhibits or prevents the adhesion of protein and/or cellular proliferation or may be a non-fouling coating.08-28-2008
20080269418OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS CONTAINING PHENYLENE-SILOXANE MACROMERS - Disclosed are soft, high refractive index, acrylic device materials having improved strength. The materials contain a phenylene-siloxane macromer.10-30-2008
20090043007OPHTHALMIC LENS MATERIALS CONTAINING CHROMOPHORES THAT ABSORB BOTH UV AND SHORT WAVELENGTH VISIBLE LIGHT - Chromophores that absorb both UV and short wavelength visible light are disclosed. The chromophores are particularly suitable for use in intraocular lens materials.02-12-2009
20090043105OPHTHALMIC LENS MATERIALS CONTAINING CHROMOPHORES THAT ABSORB BOTH UV AND SHORT WAVELENGTH VISIBLE LIGHT - Chromophores that absorb both UV and short wavelength visible light are disclosed. The chromophores are particularly suitable for use in intraocular lens materials.02-12-2009
20100012889UV-ABSORBERS FOR OPHTHALMIC LENS MATERIALS - Dihydroxybenzotriazole UV absorbing compounds that are particularly useful in ophthalmic devices are disclosed.01-21-2010
20110272645UV-ABSORBERS FOR OPHTHALMIC LENS MATERIALS - Dihydroxybenzotriazole UV absorbing compounds that are particularly useful in ophthalmic devices are disclosed.11-10-2011

Patent applications by David L. Jinkerson, Benbrook, TX US

Tammie Jinkerson, Pleasant Prairie, WI US

Patent application numberDescriptionPublished
20110275630ISOINDOLINONE KINASE INHIBITORS - Compounds having the formula:11-10-2011

Tammie K. Jinkerson, Pleasant Prairie, WI US

Patent application numberDescriptionPublished
20090062345AMIDE DERIVATIVES AS TRPV1 ANTAGONISTS - The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof,03-05-2009
20100168138Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.07-01-2010
20100267634Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.10-21-2010
20100317568Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.12-16-2010
20110082170THIENOPYRIDYL COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) AND USES THEREOF - The present invention discloses fused thienopyridyl compounds of general formula (I)04-07-2011
20110092415Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.04-21-2011
20110152250CHROMANYLUREA COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR AND USES THEREOF - Compounds that are antagonists of the VR1 receptor, having formula (I)06-23-2011
20110207699Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.08-25-2011

Patent applications by Tammie K. Jinkerson, Pleasant Prairie, WI US